AstraZeneca hikes earnings forecast after surging cancer drug sales

Nederland Nieuws Nieuws

AstraZeneca hikes earnings forecast after surging cancer drug sales
Nederland Laatste Nieuws,Nederland Headlines

Louis Goss is a MarketWatch reporter based in London.

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

Anglo-Swedish drugmaker AstraZeneca on Thursday upped its earnings forecasts for the year as surging sales of cancer medicines offset plummeting sales of COVID vaccines.

The uptick in AstraZeneca’s revenues was largely driven by a 17% increase in sales of cancer drugs at constant exchange rates, to $4.66 billion, on the back of 53% higher sales of its cancer immunotherapy drug Imfinzi. Excluding lower sales of COVID vaccines across the globe, AstraZeneca’s sales increased in all regions worldwide, apart from China, as the firm showed particularly strong growth in emerging markets.

Wij hebben dit nieuws samengevat zodat u het snel kunt lezen. Bent u geïnteresseerd in het nieuws, dan kunt u hier de volledige tekst lezen. Lees verder:

MarketWatch /  🏆 3. in NL
 

Nederland Laatste Nieuws, Nederland Headlines

Similar News:Je kunt ook nieuwsberichten lezen die vergelijkbaar zijn met deze die we uit andere nieuwsbronnen hebben verzameld.

Geopolitical clash could still spark market incident, Deutsche Bank CEO warnsGeopolitical clash could still spark market incident, Deutsche Bank CEO warnsLouis Goss is a MarketWatch reporter based in London.
Lees verder »

Uber notches earnings beat but comes up short on the top lineUber notches earnings beat but comes up short on the top lineEmily Bary is a MarketWatch news editor based in New York.
Lees verder »



Render Time: 2025-01-14 03:13:54